Biology Strategy Meeting, San Diego 2021

Biology

Strategy Meeting San Diego 2021

Unlike typical conferences, the Proventa International Strategy Meeting format is interactive and informal, where industry leaders can share insight and explore new partnerships.

25th May 2021
Hard Rock Hotel San Diego

Strategy Meetings

Biology insights without leaving your home…

Need a unique online conference experience? Looking for a chance for real discussions and genuine networking? Proventa International’s online R&D strategy meetings help you make those important connections through interactive roundtable discussions and keynote panel debates – all in a totally online format. Join biology and biology professionals from all over the USA. Engage with your senior peers, discover new insights and help take your company to the next level.

Strategy Meetings

What makes our online strategy meeting unique?

No other event creates such a unique and personalised event experience. From the tailored agenda, to the senior delegation; our online strategy meetings provide the perfect learning and networking environment from the comfort of your own home or office.

Roundtable Discussions

Intimate discussions leads by a renowned experts. Have your voice heard alongside like-minded life science executives.

Global Networking

With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Totally Online Format

It’s more important than ever to boost collaboration while promoting safety & accessibility. That’s exactly what you can expect from our online format.

Meet the Facilitators

Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the 2021 Strategy Meeting:

Yvonne Will

VP, Predictive, Investigative and Translational Toxicology (Nonclinical Safety) Janssen

Mathias Schmidt

CEO ArmaGen Inc

Dr. Schmidt joined JCR Pharmaceuticals in June 2020, overseeing global strategy, and serving as President and CEO of its subsidiaries, JCR USA and ArmaGen. He previously held the position as President and CEO of ArmaGen until the merger with JCR Pharmaceuticals in 2020. Dr. Schmidt has over 20 years of global biopharmaceutical industry experience in various strategic and operational positions including Takeda Pharmaceuticals, Nycomed GmbH, Altana Pharma, and ASTA Medica. 
After working for several years at various cancer hospitals, he joined the pharmaceutical industry in 1999, where he developed a great passion for drug discovery and development, especially for protein therapeutics in rare genetic diseases. Serving patients whose hopes for better therapies rely on us has always been front and center to his work and motivation. In 2011, he was awarded the venia legendi in pharmacology from the University of Constance, Germany. Dr. Schmidt received his academic education from the University of Stuttgart and his Ph.D. in Tumor Biology from the University of Freiburg, Germany.

Danilo Maddalo

Head of Laboratory Roche

Vuong Trieu

Chairman & CEO Mateon Therapeutics

Hiroomi Tada

Chief Medical Officer Tyra Biosciences

Werner Rubas

Vice President, Preclinical Development Sutro Biopharma, Inc.

Werner Rubas, Ph.D. brings to Sutro 30 years of biotech and pharmaceutical industry experience. Formerly, Dr. Rubas was at Nektar Therapeutics for over nine years, most recently as Executive Director in Non-Clinical Pharmacokinetics and Pharmacodynamics. At Nektar, he provided leadership support, directed the generation of data packages for regulatory submissions of NKTR-214, NKTR-358, NKTR-262, and NKTR-255, filed a patent application for an immunotherapeutic tumor treatment method, and provided scientific input on cross-functional teams from research concepts to late-stage development. Prior to Nektar, Dr. Werner was at Roche in Palo Alto, where he was the Associate Director of the Drug Metabolism and Pharmacokinetics group. Additionally, he has been a SPARK advisor at Stanford University since 2010 and lectures classes on Drug Development at UC Berkeley Extension. Dr. Rubas earned his Ph.D. from ETH, Zurich, and received his pharmacy license from the School of Pharmacy at ETH, Zurich.

Cathy Tralau-Stewart

Senior Director Alliances Takeda

John Commissiong

CSO Amarantus Therapeutics, Inc

Nick Shah

Head of In Vitro Pharmacology DiCE Molecules

Hans-peter Gerber

CEO & CSO 3T Biosciences

Reasons to Attend the Virtual Conference

Fully Interactive Virtual Conference

We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you

Personalised and Easy to Join Agenda

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join

Senior Decision Makers

All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Private and Intimate Discussions

Each sessions is read by an industry expert and the roundtables are limited to ensure you have fruitful and genuine conversations with your colleagues

Agenda